No Data
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
Watchlist
0.2894
-0.0075-2.53% Close 12/08 16:00 ET
0.2872-0.0022-0.76%
Post 19:51 ET
0.2911High0.2822Low112.21KVolume
0.2885Open0.2969Pre Close32.19KTurnover1.80%Turnover RatioLossP/E (TTM)1.89MMarket Cap2.660052wk HighLossP/E (Static)6.53MShares0.280052wk Low0.37P/B1.81MFloat Cap3718.7485Historical High--Dividend TTM6.24MShs Float0.2800Historical Low--Div YieldTTM2.98%Amplitude0.2860Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About NovaBay Pharmaceuticals Company
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Optical & Wound Care10.24M71.08%
Skin Care4.17M28.92%
News
NovaBay Pharmaceuticals Partners With Woo University To Educate Eyecare Professionals On The Use Of Amniotic Membranes
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) announces its partnership with Woo University to support the education of eyecare professionals on the use of amniotic membranes. A free webinar is being held
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersAltimmune (NASDAQ:ALT) shares increased by 45.2% to $4.59 during Thursday's after-market session. The company's market cap stands at $246.6 million. NovaBay Pharmaceuticals (AMEX:NBY) stock inc
Earnings Call: NovaBay Pharmaceuticals Reports Q3 2023 Results, Product Sales Grow and Operating Loss Decreases
Comments
$NovaBay Pharmaceuticals(NBY.US$ sorry guys, I bought some at 1.18. so it dropped.
2
1
Might be the calm before the storm though, apparently a few things are about to run up, including HKD which a little earlier this morning only had 5000 shares left to buy... And, rumor has it LGCL is going to list on a Friday in May. There's only two Fridays left... Might want to keep a *close eye* on our buddy Lucas. 
Watchlist
$NovaBay Pharmaceuticals(NBY.US$ ER 5/11 AH, 1M order will be in Q2 earnings. beat down stock.
$Myomo(MYO.US$ ER 5/10 AH, 1.7M license revenue.
$Quantum Computing(QUBT.US$ participating in Cyber security event in Minneapolis on May 8-11, might have some positive news, plus ER 5/22 PM
also will add to list:
$Nemaura Medical(NMRD.US$$Sintx Technologies(SINT.US$
$Myomo(MYO.US$ ER 5/10 AH, 1.7M license revenue.
$Quantum Computing(QUBT.US$ participating in Cyber security event in Minneapolis on May 8-11, might have some positive news, plus ER 5/22 PM
also will add to list:
$Nemaura Medical(NMRD.US$$Sintx Technologies(SINT.US$
2
Coming up
$NovaBay Pharmaceuticals(NBY.US$ Reached support of 1.25 Tuesday. Posted new higher low yesterday of 1.32. Needs to stay above 1.32 to continue up. Out of shares since Tuesday. High should be at 2.25
4
1
4
$NovaBay Pharmaceuticals(NBY.US$ TEST CAN NOT SHORT MUST NOT BUY 🔊📢👹
1
$NovaBay Pharmaceuticals(NBY.US$ only had 100 shares. what happens to the 30 shares that would have been fractional? shouldn't I just get cash back for the slightly over .85 share?
$NovaBay Pharmaceuticals(NBY.US$@Alvinnnnnnn8935 for 1 rs tmr
1
$NovaBay Pharmaceuticals(NBY.US$ as i said yesterday its buy time. ready for a major jump
1
$NovaBay Pharmaceuticals(NBY.US$ its buy time.
1
$NovaBay Pharmaceuticals(NBY.US$ this is the calm before the storm. time to buy
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--